Correction: Aberrant iPSC-derived human astrocytes in Alzheimer's disease by Jones, Vicky Claire et al.
Jones et al. Cell Death and Disease          (2019) 10:244 
https://doi.org/10.1038/s41419-019-1422-7 Cell Death & Disease
CORRECT ION Open Ac c e s s
Correction: Aberrant iPSC-derived human
astrocytes in Alzheimer’s disease
V. C. Jones1, R. Atkinson-Dell2, A. Verkhratsky2,3 and L. Mohamet2
Correction to: Cell Death & Disease 8:e2696
https://doi.org/10.1038/cddis.2017.89
published online 23 March 2017
The original version of this Article contained an error in
Fig. 1, in which a number of incorrect ﬂuorescence images
were inadvertently incorporated into the panel. The
conclusions of the paper are not changed in any way by
this correction, and the authors apologize for the
inconvenience.
The correct version of Fig. 1 is:
This has been corrected in both the PDF and HTML
versions of the Article.
© The Author(s) 2019
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: L. Mohamet (lisa.mohamet@manchester.ac.uk)
1The University of Central Lancashire, Preston PR1 2HE, UK
2The University of Manchester, Manchester M13 9PT, UK
3Achucarro Center for Neuroscience, IKERBASQUE, Basque Foundation for
Science, Bilbao 48011, Spain
Ofﬁcial journal of the Cell Death Differentiation Association
12
34
56
78
90
()
:,;
12
34
56
78
90
()
:,;
1
2
3
4
5
6
7
8
9
0
()
:,;
12
34
56
78
90
()
:,;
Fig. 1 (See legend on next page.)
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Fig. 1 Directed differentiation of healthy and AD-neural progenitor cells into cortical neurones. a–c NPCs were seeded at 1 × 105 per well and
propagated in monolayer culture for 6/7 days. FAD and SAD cortical NPCs showed indistinguishable culture morphology with healthy (control) NPCs
(N= 5 per cell line). d and e No signiﬁcant differences in NPC growth rates were identiﬁed (N= 4 per cell line, two-way Kruskal–Wallis P= NS). f–n
IPS-derived NPCs from healthy (control), FAD and SAD patients were assessed for canonical marker expression. Progenitor cells formed polarised
rosettes expressing nestin (green; f–h), PAX6 (red; i–k) and SOX1 (green, l–n). o No signiﬁcant difference in nestin+ cells was observed between
healthy and AD cell lines (N= 4 per cell line, ANOVA, F(2,9)= 0.022, P= NS). p–r Under terminal neuronal differentiation conditions for 35–40 days, all
patient samples showed positive expression of the neural marker β-III-tubulin (green). s No signiﬁcant difference in the proportion of β-III-tubulin+
neurones between any individual (N= 4 per group, ANOVA, F(2,9)= 0.128, P= NS). t–v Expression of the mature deep-layer cortical neuronal marker,
CTIP2 was observed throughout cultures from each patient (green). Scale bars, 50 μm
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